GlassScriptPhysician profile
William J Carroll
NPI 1659555258
$12,800.86
in general payments reported to CMS, 2019-2025
15 companies · $1,889 in 2025
The $1,889 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,550 · 2020: $74.78 · 2021: $1,466 · 2022: $3,803 · 2023: $913 · 2024: $105 · 2025: $1,889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,931 · Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,931.27 |
| Food and Beverage | $975.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $4,615.11 | 2019-2025 | |
| Arthrex, INC. | $3,768.10 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $1,478.56 | 2019-2025 | Juggerknotless Soft Anchor |
| Stryker Corporation | $1,107.92 | 2019-2024 | 1788 |
| Exactech, INC. | $789.79 | 2023 | |
| Smith+Nephew, INC. | $556.53 | 2019-2023 | Ultrabutton, Pico |
| Miach Orthopaedics, INC. | $141.95 | 2025 | |
| Orthalign INC | $124.43 | 2022 | |
| Depuy Synthes Sales INC. | $94.76 | 2020-2022 | |
| Bioventus LLC | $33.92 | 2019 | |
| Pacira Therapeutics, INC. | $23.47 | 2020 | |
| Abbott Laboratories | $17.90 | 2023 | Axium |
| Vericel Corporation | $17.73 | 2019 | |
| Avanos Medical | $16.66 | 2022 | |
| Ferring Pharmaceuticals INC. | $14.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Carroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.